BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome
Venkatesh Pooladanda, Sowjanya Thatikonda, Sai Priya Muvvala, Geetanjali Devabattula, Chandraiah Godugu
Topics & Concepts
ARDSMedicineCytokine stormInflammationLipopolysaccharideLungImmunologyDiffuse alveolar damagePharmacologyCancer researchPathologyInternal medicineAcute respiratory distressDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Protein Degradation and InhibitorsChromatin Remodeling and CancerPeptidase Inhibition and Analysis